Project Grant R01MH131818

Award Date 9/7/24
Completion Date 5/31/29
Dollars Obligated $535K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
This Project Grant award of $2,220,017.04 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a large-scale, single-cell characterization of the molecular and cellular networks in the mood regulation circuitry of major depressive disorder (MDD). The overarching objective is to generate single-cell transcriptomic profiles to study molecular changes, including those specific to genetic ancestry and sex, associated with MDD...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $729,821 to the University of Alabama at Birmingham (UAB) to conduct research on the role of long non-coding RNAs (lncRNAs) in the epigenetic regulation and transcriptional repatterning associated with major depressive disorder (MDD). The research aims to mechanistically examine how nuclear lncRNAs regulate 3D chromatin organization and its...
This $593,104 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to advance the understanding of the etiology of major depression (MD) by clarifying the interrelationships between genetic and environmental risk factors over developmental time. The project will leverage data from comprehensive population-based registers in Denmark and Sweden to harmonize information relevant to MD risk, develop...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $197,100 to the Research Foundation For Mental Hygiene, Inc. (RFMH) to study the role of the anterior hippocampus in the pathogenesis of major depressive disorder (MDD). The key objectives are to examine anterior hippocampal functioning and connectivity during an emotional pattern separation task using functional magnetic resonance imaging (fMRI)...
This $124,488 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to map cell type-specific isoform diversity in the human brain and dissect the mechanisms of alternative splicing in autism spectrum disorder (ASD). The project, led by Michael Margolis at the University of California, Los Angeles (UCLA), will leverage long-read sequencing technologies to fully characterize the brain's...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $184,476 to the University of Southern California to conduct a large-scale mapping of brain morphometry in Bipolar Disorder (BD) and Major Depressive Disorder (MDD). The project builds on 15 years of research by the ENIGMA Consortium's BD working group, applying standardized voxel-wise brain mapping techniques to a sample of 3,500 BD patients,...
The National Institute of Mental Health awarded a three-year Project Grant totaling $3,618,976 to the University of California, Los Angeles under the Mental Health Research Grants program (CFDA 93.242) to develop in situ single-cell multi-omic and morphological profiling methods for mammalian brains. Specifically, the university will work to design photonic-indexing sequencing strategies to spatially barcode tissue with single-cell resolution, integrating techniques such as PI-ATAC-seq and...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $162,000 over 3 years to the Research Foundation For Mental Hygiene, Inc. (RFMH) to investigate the transcriptional diversity of the human mediodorsal thalamus and its role in psychiatric disorders, specifically schizophrenia and bipolar disorder. The key objectives of this research are to: 1) use single-nucleus RNA-sequencing to define...
The National Institute of Mental Health (NIMH) awarded a $392,500 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to the Research Institute at Nationwide Children's Hospital. The 2-year award, beginning May 1, 2025, will fund research to characterize the role of sleep brain dynamics in the emergence of depression in adolescents. The study aims to: 1) identify the space-time profiles of slow oscillations and sleep spindles and compare them across youth at high and...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...

This Project Grant award of $535,153 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a large-scale, single-cell characterization of molecular and cellular networks involved in mood regulation in major depressive disorder (MDD). The project aims to identify transcriptomic changes associated with MDD in a sample of 800 subjects across three key brain regions: the anterior cingulate cortex, basolateral amygdala, and hippocampus. The research will examine the impact of genetic ancestry and sex on these transcriptomic changes, and will use machine learning to define cell networks associated with mood regulation. Additionally, the project will identify cell-specific expression quantitative trait loci (eQTLs) colocalizing with genome-wide significant SNPs from MDD genome-wide association studies. This work will be conducted by the Centre De Recherche De L'Hopital Douglas, a Canadian non-profit research organization, and is expected to be completed by May 31, 2029.

Generated 7/1/25, 5:25 AM